Colonoscopy exams get a bad rap. Even though such exams are brief and painless, many people fear and avoid them. Roughly one third of Americans for whom the exams are recommended are not getting them. Yet colonoscopy is one of the most effective of all cancer prevention methods. As many as 60% of colon cancer deaths could be … Read more
Before Oct. 31, 2012, I would have probably guessed that desensitization was a process invented by mental health professionals to make really sensitive people less sensitive. I might have inquired about the cost to put my four-year-old son through “desensitization” so that he wouldn’t throw such a fit when he lost a game of knee hockey in our basement.
Now I know that desensitization is a life-saving process necessary to treat cancer patients like me.
Medically reviewed by Paul Richardson, MD By Maria Pearson As a technology teacher who had a long career with IBM before going into education, I have encountered all sorts of opportunities to teach — and to learn. The biggest such opportunity of my life occurred at the intersection of cancer, technology, and Dana-Farber. In August … Read more
Breast cancer is the most common type of cancer in women, but men can also be diagnosed with the disease. How common is breast cancer in men? While male breast cancer is rare, according to the National Cancer Institute about 2,000 men will receive this diagnosis every year, or less than 1% of all new … Read more
Not long ago, doctors were often skeptical when cancer patients who had undergone chemotherapy complained that they were mentally foggy; unable to plan a week’s worth of meals or organize their finances as they could before. Patients called this side effect “chemobrain” and were frustrated by the lack of recognition – or suggested remedies – from their physicians.
When Gov. Deval Patrick signed an oral chemotherapy parity bill into law on January 5, Massachusetts joined more than 20 states requiring health plans to cover oral cancer pills at a rate no less favorable than standard intravenous (IV) chemotherapy. The new law tells insurers that they cannot require higher patient costs for oral chemotherapy, and it helps ensure that all forms of chemotherapy are accessible and affordable to Massachusetts cancer patients.
Win or lose, Miss America contestant Allyn Rose made news with her decision to undergo a double mastectomy. According to the Associated Press, Rose, who lost her mother to breast cancer, inherited a rare genetic mutation which might put her at greater risk for developing cancer.
Her decision to have the preventive surgery has sparked questions about genetics, cancer risk and strategies for preventing cancer.
If you have a question about genetic factors that increase cancer risk, you can ask the Dana-Farber cancer genetics team.
When Jane Davis was diagnosed with breast cancer last July, she began learning as much as she could about her disease. Davis quickly discovered one of the most startling statistics about breast cancer: Up to 40 percent of women who have a lumpectomy require a second surgery. That’s because surgeons often cannot microscopically remove the entire tumor.
But Mehra Golshan, MD, FACS, director of Breast Surgical Services at Dana-Farber/Brigham and Women’s Cancer Center, is trying to change that with a phase I breast surgery pilot study. It’s the first of its kind in the world.
This post was originally published in December 2012.
When it comes to treating prostate cancer, proton radiotherapy (PRT) is no better than traditional intensity-modulated radiation therapy (IMRT), according to a new study reported in the Journal of the National Cancer Institute on Friday.
PRT is an advanced but expensive treatment option for some prostate cancer patients. However, the researchers found that the therapy offers no added treatment benefit than the standard therapy. The article concluded: “Although PRT is substantially more costly than IMRT, there was no difference in toxicity in a comprehensive cohort of Medicare beneficiaries with prostate cancer at 12 months post-treatment.”
While there are genetic and lifestyle risks for breast cancer, some may not realize that breast density also plays a significant role in risk for the disease. Breasts are considered dense if they are mostly made up of glandular and fibrous tissue and not much fat. Breast density can be seen only on a mammogram; the firmness of breasts is … Read more
While other kinds of cancer may receive more public attention, lung cancer remains the leading cause of cancer deaths. There are two main types of lung cancer: small cell carcinoma and non-small cell carcinoma, both of which mainly affect people over 45 years old.
We spoke with Bruce E. Johnson, MD about causes and treatment options.
On Thanksgiving Day every year, Marc Kutzer and his sister, Roberta Klein, have much to be thankful for.
In 2001, Kutzer went to his primary care physician for a routine physical. What his doctor discovered led Kutzer, 52, to Dana-Farber — and to a procedure he credits for saving not only his life, but also his sister’s.
A stem cell transplant can be referred to as a bone marrow transplant (BMT) or peripheral blood stem cell transplant (PBSCT) or umbilical cord blood transplantation (UCBT), depending on the source of the cells that are transplanted. In other words, the only real distinction between a bone marrow transplant and a stem cell transplant in the method … Read more
There has been remarkable recent progress in identifying effective treatments for patients with metastatic breast cancer – that is, cancer that has spread beyond the breast and underarm lymph nodes to other parts of the body.
By Lola Baltzell
I have been a metastatic breast cancer patient at Dana-Farber for over four years now. I have an amazing team of providers, especially my oncologist Ann Partridge, MD, MPH, and nurse practitioner Anne Kelly, MSN, NP.
Aromatase inhibitors (AIs), such as Arimidex, Aromasin, and Femara, have proven to be more effective than previous hormonal treatments for treating both early and advanced breast cancer in post-menopausal women whose tumors are dependent on estrogen. Compared with tamoxifen, these drugs are less likely to cause blood clots or raise the risk of endometrial cancer. As a result, AIs are used both in patients with early breast cancer and in those with metastatic disease.
It was glitter and glue when patients, visitors, and Dana-Farber staff gathered on Oct. 4 to create art on an unusual canvas – bras. Hosted by Friends’ Place and Dana-Farber’s Creative Arts Program, the “Decorate a Brassiere” art therapy event allowed attendees to creatively honor Breast Cancer Awareness Month.
In 2012, it is estimated that more than 22,000 new cases of ovarian cancer will be found, and over 15,000 women will die from the disease, according to the National Cancer Institute. Unfortunately, in many cases the cancer isn’t detected until it is advanced. It’s important to recognize the symptoms and urge the women in your life to take early action.
September is Ovarian Cancer Awareness Month and in recognition of that, we asked ovarian cancer survivor Margaret Winchester to share her story.
After being diagnosed with advanced (stage IIIC) ovarian cancer in 2008, I chose Dana-Farber for my care because I knew about the Institute’s cutting-edge approach to cancer care and research.
Just as people may wheeze and itch in the presence of cats or pollen, a minority of cancer patients become allergic to the very drugs that are fighting their disease.